KLK3 and metastatic neoplasm: However, PSA screening recommendations made by the USPSTF in 2012 led to a decline in PSA screening, which resulted in an increase in the incidence of high-risk and metastatic disease at diagnosis, particularly in certain racial and ethnic groups (2–4).